Skip to main content

Volatile Sensex, Nifty gain strength; Sun Pharma rallies

11:40am FII View: Mahesh Nandurkar, CLSA said interactions with 80 investors in the USA suggest FIIs' incremental interest in India is near a short-term peak. With most being overweight, there is an increasing unease about weak earnings, he added.

The brokerage still expects profit to improve, just not in the next couple of seasons, he said.

"The macro triggers of Land/GST bills also seem to be some time away. The structural story remains compelling for long-term investors but the risk of a near-term pullback is rising. We lower our weights on banks and capital goods," he explained.

11:25am Gammon Infra under pressure: Sebi refused to withdraw the ban on Abhijit Rajan, former CMD of Gammon Infrastructure Projects, from the securities market and said the prohibition will continue till further directions in a case related to insider trading.

The market regulator, in its order in July last year, had barred Rajan after prima-facie finding him to have violated insider trading regulations. This would be one of the few cases where CMD of a company has come under the scanner in an insider trading case.

In an order passed on Monday, Sebi has confirmed the directions issued in respect of Rajan vide ad-interim ex-parte order dated July 17, 2014. The directions issued vide the interim order "shall continue to be in force till further directions," it added.

11:00am Market Check:

The market remained firm with the Nifty bouncing back after 4 days of consecutive losses. The broader markets gained marginally more than the frontline indices with a firm advance:decline ratio.

The Sensex rose 109.22 points to 28301.24 and the Nifty advanced 31.20 points to 8582.10.

From the frontliners, Jindal Steel gained 2 percent on news of the Delhi High Court staying the transfer of Tara coal block and asking the government to file reasons for transferring the Gare-Palma IV 2 & 3 blocks by March 26.

Sun Pharma rallied 2 percent along with Ranbaxy Labs. The CCI approved Sun-Ranbaxy's plan to divest all 7 brands to Emcure Pharma. Strides Arcolab and Shasun Pharma too gained 3-5 percent as the CCI gave its approval to the proposed merger between the two entities. However, Aarti Drugs plunged 9 percent as the USFDA issued an import alert on the company's Palghar unit. More information please visit this site www.shristocktips.com



Comments

Popular posts from this blog

Nifty could slip towards 9,900; 3 stocks which could give up to 11% return

A close beyond 10,400 levels with healthy volumes can pause the current bearishness triggering a short covering to levels of 10,640-10,730.

The Nifty index Futures continued to slide lower for the second month in a row making it 10 percent decline from the record highs. Further, it has broken down from a broadening wedge pattern along with a close below the 200-DMA, affirming weakness dominant in the markets at the moment.

A sustained trade below 10,050 can accelerate the fall to levels of 9,930-9,700. However, a close beyond 10,400 levels with healthy volumes can pause the current bearishness triggering a short covering to levels of 10,640-10,730.

Moreover, the relative strength index or the RSI has turned down from the neutral levels of 50 on two occasions in recent pullbacks suggesting further weakness in the coming trading sessions.

Here is the list of stocks which can give up to 11 percent return:

Arvind Ltd: SELL| Target Rs345| Stop Loss Rs410| Return 11%

On the weekly chart, Arv…

Market Update: PSU bank index outperforms as PNB, Syndicate Bank jump 2-5%; JP Associates zooms 11%

The market breadth was in favour of the advances with 957 stocks advancing while 668 declined and 383 remained unchanged. On the other hand, in the BSE, 1176 stocks advanced and 888 declined and 108 remained unchanged.

The Indian markets on Friday morning were trading flat with the Nifty shedding 51 points or 0.49 percent  while the Sensex was down 178 points.

The Nifty PSU banking index was up 0.6 percent led by stocks like Syndicate Bank which jumped 5 percent followed by Allahabad Bank which gained over 3 percent. IDBI Bank and OBC were the other gainers. PNB gained 2.38 percent.

The top Nifty gainers included Mahindra & Mahindra and Aurobindo Pharma which were up 1.7 percent each followed by UPL, Yes Bank and Zee Entertainment.

The top Nifty losers included IOC and BPCL which fell 2 percent each followed by HPCL, Tata Motors and NTPC.

The most active Nifty stocks included IDBI bank which jumped over 3 percent while JP Associates zoomed over 10 percent after Rakesh Jhunjhunwala…

HDFC Sec retains sell on Bharti Infratel, reduces target to Rs 310 despite 22% fall in last 2 months

The share price has declined from a peak of Rs 480 to Rs 373 (22 percent) in last two months.

Bharti Infratel shares declined 1.5 percent to close at Rs 368 on Tuesday after HDFC Securities has reiterated its Sell rating on the stock with revised target price at Rs 310 (from Rs 387 per share) despite sharp fall in last two months. INDIAN STOCK TIPS

The share price has declined from a peak of Rs 480 to Rs 373 (22 percent) in last two months.

"Target price is based on 20x Dec-19E EPS (Rs 356) for business as usual (versus 24x earlier) less impact of Rs 60 per share from Vodafone-Idea merger (versus Rs 39 per share earlier) and likely acquisition of Vodafone-Idea stake in Indus at enterprise value of Rs 50 lakh per tower (+Rs 15 per share)," the research house said.

It further said the key reason for the de-rating is instant loss of tenancies on merger of Vodafone-Idea and impact of Reliance Communications and Aircel businesses’ scaling down.

This would push back Bharti Infrat…